{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:41:40Z","timestamp":1791452500277,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.drugalcdep.2018.08.014","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T16:27:52Z","timestamp":1540225672000},"page":"148-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland"],"prefix":"10.1016","volume":"195","author":[{"given":"Susan G.","family":"Sherman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin E.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Nyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Patrick","family":"Chaulk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0005","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s10461-013-0593-y","article-title":"Effectiveness of structural-level needle\/syringe programs to reduce HCV and HIV infection among people who inject drugs: A systematic review","volume":"17","author":"Abdul-Quader","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M15-2634","article-title":"Cost-effectiveness of HIV preexposure prophylaxis for people who inject drugs in the United States","volume":"165","author":"Bernard","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1521-0391.1992.tb00353.x","article-title":"Effectiveness of reducing needle-related risks for HIV through indigenous outreach to injection drug users","volume":"1","author":"Booth","year":"1992","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/jvh.12008","article-title":"Accessing Hepatitis C patients who are difficult to reach: It is time to overcome barriers","volume":"19","author":"Bruggmann","year":"2012","journal-title":"J. Viral. Hepat."},{"issue":"Suppl. 3","key":"10.1016\/j.drugalcdep.2018.08.014_bib0025","doi-asserted-by":"crossref","first-page":"19949","DOI":"10.7448\/IAS.18.4.19949","article-title":"The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention","volume":"18","author":"C\u00e1ceres","year":"2015","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/cid\/cix333","article-title":"Geographic disparities in access to syringe services programs among young persons with hepatitis c virus infection in the United States","volume":"65","author":"Canary","year":"2017","journal-title":"Clin. Res. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0035","series-title":"Preexposure prophylaxis for the prevention of HIV infection in the United States-2014: A clinical practice guideline","author":"Centers for Disease Control and Prevention (CDC)","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0040","first-page":"1","article-title":"Diagnoses of HIV infection in the United States and dependent areas, 2015","volume":"27","author":"Centers for Disease Control and Prevention (CDC)","year":"2016","journal-title":"HIV Surveill. Rep."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0045","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"2016","author":"Compton","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0055","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2105\/AJPH.2011.300130","article-title":"Associations between herpes simplex virus type 2 and HCV with HIV among injecting drug users in New York City: The current importance of sexual transmission of HIV","volume":"101","author":"Des Jarlais","year":"2011","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0060","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","article-title":"Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013","volume":"64","author":"Des Jarlais","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028238","article-title":"Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study","volume":"7","author":"Eisingerich","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0070","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s10461-014-0867-z","article-title":"Acceptability of HIV pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) in a Canadian setting","volume":"19","author":"Escudero","year":"2015","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe programmes in people who inject drugs\u2013An overview of systematic reviews","volume":"17","author":"Fernandes","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0080","series-title":"Truvada for PrEP fact sheet: Ensuring safe and proper use","author":"Food and Drug Administration (FDA)","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/00380237.1999.10571131","article-title":"Networks, norms and solidaristic\/altruistic action against AIDS among the demonized","volume":"32","author":"Friedman","year":"1999","journal-title":"Sociol. Focus"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0090","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200107270-00002","article-title":"Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users","volume":"15","author":"Gibson","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0095","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0100","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/add.13437","article-title":"\u2018PrEP is not ready for our community, and our community is not ready for PrEP\u2019: Pre\u2010exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response","volume":"112","author":"Guise","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2016.02.044","article-title":"Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC","volume":"164","author":"Kuo","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1037\/0278-6133.22.4.332","article-title":"HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention","volume":"22","author":"Latkin","year":"2003","journal-title":"Health Psychol."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0955-3959(03)00133-6","article-title":"Effectiveness of needle and syringe programmes for preventing HIV transmission","volume":"14","author":"MacDonald","year":"2003","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0120","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/COH.0000000000000159","article-title":"Planning ahead for implementation of long acting HIV prevention: Challenges and opportunities","volume":"10","author":"Meyers","year":"2015","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCULATIONAHA.105.588103","article-title":"National study of women\u2019s awareness, preventive action, and barriers to cardiovascular health","volume":"113","author":"Mosca","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0135","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s10461-013-0496-y","article-title":"Dual HIV risk: Receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City","volume":"17","author":"Neaigus","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0140","first-page":"165","article-title":"Design and estimation for the national health interview survey, 2006-2015","volume":"2","author":"Parsons","year":"2014","journal-title":"Vital. Health Stat."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.12.023","article-title":"Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug-and sex-related behaviors among high-risk drug users on methadone treatment","volume":"173","author":"Shrestha","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0150","series-title":"Stata Statistical Software: Release 14. StataCorp LP","author":"StataCorp","year":"2015"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0155","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s10461-014-0778-z","article-title":"Willingness to use HIV pre-exposure prophylaxis among opiate users","volume":"18","author":"Stein","year":"2014","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0160","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archinte.161.10.1281","article-title":"Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective","volume":"161","author":"Strathdee","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0165","first-page":"323","article-title":"County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States","volume":"73","author":"Van Handel","year":"2016","journal-title":"J. AIDS"},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12954-017-0166-x","article-title":"Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention","volume":"14","author":"Walters","year":"2017","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2018.08.014_bib0175","first-page":"S383","article-title":"Differences in awareness of pre-exposure prophylaxis and post-exposure prophylaxis among groups at-risk for HIV in New York State: New York City and Long Island, NY, 2011\u20132013","volume":"75","author":"Walters","year":"2017","journal-title":"J. AIDS."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161830646X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161830646X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T19:53:06Z","timestamp":1605297186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161830646X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":35,"alternative-id":["S037687161830646X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.08.014","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}